Gene-Chemical Interaction Annotations Click to see Annotation Detail View
Term | Qualifier | Evidence | With | Reference | Notes | Source | Original Reference(s) | (-)-epigallocatechin 3-gallate | multiple interactions | ISO | RBMS1 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RBMS1 mRNA | CTD | PMID:22079256 | (1->4)-beta-D-glucan | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RBMS1 mRNA | CTD | PMID:36331819 | 1,2-dichloroethane | decreases expression | EXP | | 6480464 | ethylene dichloride results in decreased expression of RBMS1 mRNA | CTD | PMID:28189721 and PMID:28960355 | 17beta-estradiol | multiple interactions | ISO | RBMS1 (Homo sapiens) | 6480464 | EGF protein inhibits the reaction [Estradiol results in decreased expression of RBMS1 mRNA] | CTD | PMID:24758408 | 17beta-estradiol | decreases expression | ISO | Rbms1 (Rattus norvegicus) | 6480464 | Estradiol results in decreased expression of RBMS1 mRNA | CTD | PMID:32145629 | 17beta-estradiol | decreases expression | ISO | RBMS1 (Homo sapiens) | 6480464 | Estradiol results in decreased expression of RBMS1 mRNA | CTD | PMID:19167446 and PMID:24758408 | 2,2',4,4',5,5'-hexachlorobiphenyl | multiple interactions | EXP | | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,2',5,5'-tetrachlorobiphenyl | multiple interactions | EXP | | 6480464 | [2 more ... | CTD | PMID:25510870 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | Rbms1 (Rattus norvegicus) | 6480464 | Tetrachlorodibenzodioxin affects the expression of RBMS1 mRNA | CTD | PMID:22298810 and PMID:34747641 | 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of RBMS1 mRNA | CTD | PMID:21570461 | 3,3',4,4',5-pentachlorobiphenyl | decreases expression | ISO | Rbms1 (Rattus norvegicus) | 6480464 | 3 more ... | CTD | PMID:23196670 | 4,4'-sulfonyldiphenol | increases expression | EXP | | 6480464 | bisphenol S results in increased expression of RBMS1 mRNA | CTD | PMID:30951980 | 4,4'-sulfonyldiphenol | increases expression | ISO | RBMS1 (Homo sapiens) | 6480464 | bisphenol S results in increased expression of RBMS1 protein | CTD | PMID:34186270 | 4,4'-sulfonyldiphenol | multiple interactions | ISO | Rbms1 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RBMS1 mRNA | CTD | PMID:36041667 | acetamide | increases expression | ISO | Rbms1 (Rattus norvegicus) | 6480464 | acetamide results in increased expression of RBMS1 mRNA | CTD | PMID:31881176 | aflatoxin B1 | decreases methylation | ISO | RBMS1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in decreased methylation of RBMS1 gene | CTD | PMID:27153756 | aflatoxin B1 | increases expression | ISO | RBMS1 (Homo sapiens) | 6480464 | Aflatoxin B1 results in increased expression of RBMS1 mRNA | CTD | PMID:27153756 | all-trans-retinoic acid | affects expression | ISO | RBMS1 (Homo sapiens) | 6480464 | Tretinoin affects the expression of RBMS1 mRNA | CTD | PMID:16054129 | all-trans-retinoic acid | increases expression | ISO | RBMS1 (Homo sapiens) | 6480464 | Tretinoin results in increased expression of RBMS1 mRNA | CTD | PMID:23724009 and PMID:33167477 | antirheumatic drug | decreases expression | ISO | RBMS1 (Homo sapiens) | 6480464 | Antirheumatic Agents results in decreased expression of RBMS1 mRNA | CTD | PMID:24449571 | aristolochic acid A | decreases expression | ISO | RBMS1 (Homo sapiens) | 6480464 | aristolochic acid I results in decreased expression of RBMS1 mRNA | CTD | PMID:33212167 | Aroclor 1254 | decreases expression | EXP | | 6480464 | Chlorodiphenyl (54% Chlorine) results in decreased expression of RBMS1 mRNA | CTD | PMID:23650126 | arsane | affects expression | ISO | RBMS1 (Homo sapiens) | 6480464 | Arsenic affects the expression of RBMS1 mRNA | CTD | PMID:18414638 | arsenic atom | affects expression | ISO | RBMS1 (Homo sapiens) | 6480464 | Arsenic affects the expression of RBMS1 mRNA | CTD | PMID:18414638 | benzene | affects expression | ISO | RBMS1 (Homo sapiens) | 6480464 | Benzene affects the expression of RBMS1 mRNA | CTD | PMID:16188086 | benzo[a]pyrene | decreases expression | ISO | RBMS1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased expression of RBMS1 mRNA | CTD | PMID:20064835 | benzo[a]pyrene | decreases methylation | ISO | RBMS1 (Homo sapiens) | 6480464 | Benzo(a)pyrene results in decreased methylation of RBMS1 promoter | CTD | PMID:27901495 | benzo[a]pyrene | decreases methylation | EXP | | 6480464 | Benzo(a)pyrene results in decreased methylation of RBMS1 intron | CTD | PMID:27901495 | benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of RBMS1 mRNA | CTD | PMID:22228805 | benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of RBMS1 mRNA | CTD | PMID:19770486 | benzo[a]pyrene diol epoxide I | decreases expression | ISO | RBMS1 (Homo sapiens) | 6480464 | 7 more ... | CTD | PMID:19150397 | bisphenol A | increases expression | EXP | | 6480464 | bisphenol A results in increased expression of RBMS1 mRNA | CTD | PMID:26063408 | bisphenol A | multiple interactions | ISO | Rbms1 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RBMS1 mRNA | CTD | PMID:36041667 | bisphenol A | decreases expression | ISO | RBMS1 (Homo sapiens) | 6480464 | bisphenol A results in decreased expression of RBMS1 protein | CTD | PMID:33376534 and PMID:34186270 | bisphenol A | decreases expression | ISO | Rbms1 (Rattus norvegicus) | 6480464 | bisphenol A results in decreased expression of RBMS1 mRNA | CTD | PMID:32145629 | bisphenol F | increases expression | EXP | | 6480464 | bisphenol F results in increased expression of RBMS1 mRNA | CTD | PMID:30951980 | bisphenol F | multiple interactions | ISO | Rbms1 (Rattus norvegicus) | 6480464 | [bisphenol A co-treated with bisphenol F co-treated with bisphenol S] results in increased expression of RBMS1 mRNA | CTD | PMID:36041667 | bisphenol F | increases expression | ISO | RBMS1 (Homo sapiens) | 6480464 | bisphenol F results in increased expression of RBMS1 protein | CTD | PMID:34186270 | caffeine | increases phosphorylation | ISO | RBMS1 (Homo sapiens) | 6480464 | Caffeine results in increased phosphorylation of RBMS1 protein | CTD | PMID:35688186 | carbon nanotube | decreases expression | ISO | RBMS1 (Homo sapiens) | 6480464 | Nanotubes and Carbon results in decreased expression of RBMS1 mRNA | CTD | PMID:28673683 | CGP 52608 | multiple interactions | ISO | RBMS1 (Homo sapiens) | 6480464 | CGP 52608 promotes the reaction [RORA protein binds to RBMS1 gene] | CTD | PMID:28238834 | chlordecone | decreases expression | EXP | | 6480464 | Chlordecone results in decreased expression of RBMS1 mRNA | CTD | PMID:29980752 | choline | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RBMS1 gene | CTD | PMID:20938992 | ciglitazone | multiple interactions | ISO | RBMS1 (Homo sapiens) | 6480464 | [ciglitazone binds to PPARG protein] which results in increased expression of RBMS1 mRNA | CTD | PMID:16197558 | ciguatoxin CTX1B | affects expression | EXP | | 6480464 | Ciguatoxins affects the expression of RBMS1 mRNA | CTD | PMID:18353800 | clothianidin | decreases expression | ISO | RBMS1 (Homo sapiens) | 6480464 | clothianidin results in decreased expression of RBMS1 mRNA | CTD | PMID:31626844 | cobalt dichloride | decreases expression | ISO | RBMS1 (Homo sapiens) | 6480464 | cobaltous chloride results in decreased expression of RBMS1 mRNA | CTD | PMID:19320972 | coumestrol | decreases expression | ISO | RBMS1 (Homo sapiens) | 6480464 | Coumestrol results in decreased expression of RBMS1 mRNA | CTD | PMID:19167446 | coumestrol | multiple interactions | ISO | RBMS1 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 more ... | CTD | PMID:19167446 | cyclosporin A | increases expression | ISO | RBMS1 (Homo sapiens) | 6480464 | Cyclosporine results in increased expression of RBMS1 mRNA | CTD | PMID:20106945 | cyclosporin A | decreases expression | ISO | RBMS1 (Homo sapiens) | 6480464 | Cyclosporine results in decreased expression of RBMS1 mRNA | CTD | PMID:25562108 | dibutyl phthalate | increases expression | EXP | | 6480464 | Dibutyl Phthalate results in increased expression of RBMS1 mRNA | CTD | PMID:21266533 | diethylstilbestrol | decreases expression | ISO | RBMS1 (Homo sapiens) | 6480464 | Diethylstilbestrol results in decreased expression of RBMS1 mRNA | CTD | PMID:36621641 | dorsomorphin | multiple interactions | ISO | RBMS1 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RBMS1 mRNA | CTD | PMID:27188386 | doxorubicin | decreases expression | ISO | RBMS1 (Homo sapiens) | 6480464 | Doxorubicin results in decreased expression of RBMS1 mRNA | CTD | PMID:29803840 | elemental selenium | decreases expression | ISO | RBMS1 (Homo sapiens) | 6480464 | Selenium results in decreased expression of RBMS1 mRNA | CTD | PMID:19244175 | elemental selenium | increases expression | ISO | RBMS1 (Homo sapiens) | 6480464 | Selenium results in increased expression of RBMS1 mRNA | CTD | PMID:19244175 | Enterolactone | multiple interactions | ISO | RBMS1 (Homo sapiens) | 6480464 | [Coumestrol co-treated with 2 and 3-bis(3'-hydroxybenzyl)butyrolactone] results in decreased expression of RBMS1 mRNA | CTD | PMID:19167446 | entinostat | decreases expression | ISO | RBMS1 (Homo sapiens) | 6480464 | entinostat results in decreased expression of RBMS1 mRNA | CTD | PMID:26272509 | entinostat | multiple interactions | ISO | RBMS1 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RBMS1 mRNA | CTD | PMID:27188386 | fenthion | increases expression | EXP | | 6480464 | Fenthion results in increased expression of RBMS1 mRNA | CTD | PMID:34813904 | flutamide | decreases expression | ISO | Rbms1 (Rattus norvegicus) | 6480464 | Flutamide results in decreased expression of RBMS1 mRNA | CTD | PMID:24136188 | folic acid | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RBMS1 gene | CTD | PMID:20938992 | folic acid | decreases expression | EXP | | 6480464 | Folic Acid results in decreased expression of RBMS1 mRNA | CTD | PMID:25629700 | genistein | increases methylation | ISO | Rbms1 (Rattus norvegicus) | 6480464 | Genistein results in increased methylation of RBMS1 gene | CTD | PMID:28505145 | hydrogen peroxide | affects expression | ISO | RBMS1 (Homo sapiens) | 6480464 | Hydrogen Peroxide affects the expression of RBMS1 mRNA | CTD | PMID:21179406 | inulin | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of RBMS1 mRNA | CTD | PMID:36331819 | irinotecan | decreases response to substance | ISO | RBMS1 (Homo sapiens) | 6480464 | RBMS1 protein results in decreased susceptibility to Irinotecan | CTD | PMID:16734730 | isobutanol | multiple interactions | ISO | RBMS1 (Homo sapiens) | 6480464 | [[Gasoline co-treated with isobutyl alcohol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of RBMS1 mRNA | CTD | PMID:29432896 | ketamine | decreases expression | ISO | Rbms1 (Rattus norvegicus) | 6480464 | Ketamine results in decreased expression of RBMS1 mRNA | CTD | PMID:20080153 | L-methionine | multiple interactions | EXP | | 6480464 | [Methionine deficiency co-treated with Choline deficiency co-treated with Folic Acid deficiency] results in increased methylation of RBMS1 gene | CTD | PMID:20938992 | lead(0) | decreases expression | ISO | RBMS1 (Homo sapiens) | 6480464 | Lead results in decreased expression of RBMS1 mRNA | CTD | PMID:19921347 | menadione | affects expression | ISO | RBMS1 (Homo sapiens) | 6480464 | Vitamin K 3 affects the expression of RBMS1 mRNA | CTD | PMID:20044591 | methapyrilene | decreases expression | ISO | Rbms1 (Rattus norvegicus) | 6480464 | Methapyrilene results in decreased expression of RBMS1 mRNA | CTD | PMID:30467583 | methotrexate | affects response to substance | ISO | RBMS1 (Homo sapiens) | 6480464 | RBMS1 protein affects the susceptibility to Methotrexate | CTD | PMID:16217747 | oxaliplatin | multiple interactions | ISO | Rbms1 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of RBMS1 mRNA | CTD | PMID:25729387 | paracetamol | affects expression | EXP | | 6480464 | Acetaminophen affects the expression of RBMS1 mRNA | CTD | PMID:17562736 | paracetamol | decreases expression | ISO | Rbms1 (Rattus norvegicus) | 6480464 | Acetaminophen results in decreased expression of RBMS1 mRNA | CTD | PMID:33387578 | PCB138 | multiple interactions | EXP | | 6480464 | [2 more ... | CTD | PMID:25510870 | perfluorooctane-1-sulfonic acid | multiple interactions | EXP | | 6480464 | [perfluorooctane sulfonic acid co-treated with Cellulose] results in decreased expression of RBMS1 mRNA and [perfluorooctane sulfonic acid co-treated with Inulin] results in decreased expression of RBMS1 mRNA | CTD | PMID:36331819 | phenobarbital | affects expression | EXP | | 6480464 | Phenobarbital affects the expression of RBMS1 mRNA | CTD | PMID:23091169 | potassium chromate | decreases expression | ISO | RBMS1 (Homo sapiens) | 6480464 | potassium chromate(VI) results in decreased expression of RBMS1 mRNA | CTD | PMID:22079256 | potassium chromate | multiple interactions | ISO | RBMS1 (Homo sapiens) | 6480464 | [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of RBMS1 mRNA | CTD | PMID:22079256 | propiconazole | decreases expression | EXP | | 6480464 | propiconazole results in decreased expression of RBMS1 mRNA | CTD | PMID:21278054 | quercetin | decreases expression | ISO | RBMS1 (Homo sapiens) | 6480464 | Quercetin results in decreased expression of RBMS1 mRNA | CTD | PMID:15309432 | resveratrol | multiple interactions | ISO | RBMS1 (Homo sapiens) | 6480464 | [Coumestrol co-treated with resveratrol] results in decreased expression of RBMS1 mRNA | CTD | PMID:19167446 | resveratrol | decreases expression | ISO | RBMS1 (Homo sapiens) | 6480464 | resveratrol results in decreased expression of RBMS1 mRNA | CTD | PMID:19167446 and PMID:25888808 | resveratrol | decreases expression | ISO | Rbms1 (Rattus norvegicus) | 6480464 | resveratrol results in decreased expression of RBMS1 mRNA | CTD | PMID:25905778 | rimonabant | multiple interactions | EXP | | 6480464 | Rimonabant inhibits the reaction [Dietary Fats results in increased expression of RBMS1 mRNA] | CTD | PMID:19030233 | SB 431542 | multiple interactions | ISO | RBMS1 (Homo sapiens) | 6480464 | [NOG protein co-treated with entinostat co-treated with dorsomorphin co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide] results in decreased expression of RBMS1 mRNA | CTD | PMID:27188386 | selenium atom | decreases expression | ISO | RBMS1 (Homo sapiens) | 6480464 | Selenium results in decreased expression of RBMS1 mRNA | CTD | PMID:19244175 | selenium atom | increases expression | ISO | RBMS1 (Homo sapiens) | 6480464 | Selenium results in increased expression of RBMS1 mRNA | CTD | PMID:19244175 | serpentine asbestos | increases methylation | ISO | RBMS1 (Homo sapiens) | 6480464 | Asbestos and Serpentine results in increased methylation of RBMS1 gene | CTD | PMID:29523930 | silver atom | decreases expression | EXP | | 6480464 | Silver results in decreased expression of RBMS1 mRNA | CTD | PMID:27131904 | silver(0) | decreases expression | EXP | | 6480464 | Silver results in decreased expression of RBMS1 mRNA | CTD | PMID:27131904 | sodium arsenite | affects methylation | ISO | RBMS1 (Homo sapiens) | 6480464 | sodium arsenite affects the methylation of RBMS1 gene | CTD | PMID:28589171 | Soman | increases expression | ISO | Rbms1 (Rattus norvegicus) | 6480464 | Soman results in increased expression of RBMS1 mRNA | CTD | PMID:19281266 | tetrachloromethane | increases expression | EXP | | 6480464 | Carbon Tetrachloride results in increased expression of RBMS1 mRNA | CTD | PMID:27339419 | tetrachloromethane | increases expression | ISO | Rbms1 (Rattus norvegicus) | 6480464 | Carbon Tetrachloride results in increased expression of RBMS1 mRNA | CTD | PMID:31150632 | topotecan | multiple interactions | ISO | Rbms1 (Rattus norvegicus) | 6480464 | [oxaliplatin co-treated with Topotecan] results in decreased expression of RBMS1 mRNA | CTD | PMID:25729387 | troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of RBMS1 mRNA | CTD | PMID:28973697 | tungsten | decreases expression | EXP | | 6480464 | Tungsten results in decreased expression of RBMS1 mRNA | CTD | PMID:30912803 | valproic acid | decreases methylation | ISO | RBMS1 (Homo sapiens) | 6480464 | Valproic Acid results in decreased methylation of RBMS1 gene | CTD | PMID:29154799 | vitamin E | decreases expression | ISO | RBMS1 (Homo sapiens) | 6480464 | Vitamin E results in decreased expression of RBMS1 mRNA | CTD | PMID:19244175 | zinc atom | multiple interactions | ISO | RBMS1 (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of RBMS1 mRNA | CTD | PMID:18593933 | zinc(0) | multiple interactions | ISO | RBMS1 (Homo sapiens) | 6480464 | [PCI 5002 co-treated with Zinc] results in increased expression of RBMS1 mRNA | CTD | PMID:18593933 | | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
 |
Welcome {{ username}}
Message Center
{{ messageCount }} Messages
Watched Genes
{{$index + 1}}. {{ watchedObject.symbol }} (RGD ID:{{watchedObject.rgdId}})
Watched Ontology Terms
{{gene.symbol}}: {{ gene.description }}
|
| You must be logged in to use this feature |
| {{ loginError }} |
|
|
Analyze GeneStrainQTL List |
 Gene Annotator (Functional Annotation) unavailable |
 Gene Annotator (Annotation Distribution) unavailable |
 Variant Visualizer (Genomic Variants) unavailble Variant Visualizer (Genomic Variants) unavailable |
Gene Annotator (Functional Annotation) |
Gene Annotator (Annotation Distribution) |
Variant Visualizer (Genomic Variants) |
 InterViewer (Protein-Protein Interactions) unavailable |
 Gviewer (Genome Viewer) unavailable |
 Variant Visualizer (Damaging Variants) unavailble Variant Visualizer (Damaging Variants) unavailable |
InterViewer (Protein-Protein Interactions) |
GViewer (Genome Viewer) |
Variant Visualizer (Damaging Variants) |
 Gene Annotator (Annotation Comparison) unavailable |
 OLGA (Gene List Generator) unavailable |
 |
Gene Annotator (Annotation Comparison) |
OLGA (Gene List Generator) |
Excel (Download) |
 MOET (Multi-Ontology Enrichement) unavailable |
 GOLF (Gene-Ortholog Location Finder) unavailable |
|
MOET (Multi-Ontology Enrichement) |
GOLF (Gene-Ortholog Location Finder) |
|
||||||||||
Gene Ontology Annotations Click to see Annotation Detail View
Biological Process
Cellular Component
Molecular Function
Phenotype Annotations Click to see Annotation Detail View
Mammalian Phenotype
Disease Annotations
Click to see Annotation Detail View
|
|
Gene-Chemical Interaction Annotations
Click to see Annotation Detail View
Gene Ontology Annotations
Click to see Annotation Detail View
Molecular Function
|
|
|
Phenotype Annotations
Click to see Annotation Detail View
Mammalian Phenotype
|
|
|
References
References - curated
| # | Reference Title | Reference Citation |
| 1. | Functional annotation of a full-length mouse cDNA collection. | Kawai J, etal., Nature. 2001 Feb 8;409(6821):685-90. |
| 2. | MGDs mouse GO annotations | MGD data from the GO Consortium |
| 3. | MGD IEA | MGD IEA |
| 4. | Analysis of the mouse transcriptome based on functional annotation of 60,770 full-length cDNAs. | Okazaki Y, etal., Nature. 2002 Dec 5;420(6915):563-73. |
| 5. | Mouse MP Annotation Import Pipeline | RGD automated import pipeline |
| 6. | Data Import for Chemical-Gene Interactions | RGD automated import pipeline for gene-chemical interactions |
Additional References at PubMed
| PMID:8889548 | PMID:10349636 | PMID:10639566 | PMID:10922068 | PMID:11042159 | PMID:11076861 | PMID:11737267 | PMID:12477932 | PMID:12520002 | PMID:12904583 | PMID:14610273 | PMID:15489334 |
| PMID:15782199 | PMID:15817157 | PMID:16033648 | PMID:16141072 | PMID:16141073 | PMID:16602821 | PMID:17967808 | PMID:18799693 | PMID:20860848 | PMID:21677750 | PMID:21873635 | PMID:22593182 |
| PMID:24194600 | PMID:27626380 | PMID:32098917 | PMID:32325033 | PMID:35476669 | PMID:35754370 | PMID:37511060 | PMID:38288506 |
Genomics
Comparative Map Data
| Rbms1 (Mus musculus - house mouse) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RBMS1 (Homo sapiens - human) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Rbms1 (Rattus norvegicus - Norway rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Rbms1 (Chinchilla lanigera - long-tailed chinchilla) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RBMS1 (Pan paniscus - bonobo/pygmy chimpanzee) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RBMS1 (Canis lupus familiaris - dog) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Rbms1 (Ictidomys tridecemlineatus - thirteen-lined ground squirrel) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RBMS1 (Sus scrofa - pig) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RBMS1 (Chlorocebus sabaeus - green monkey) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Rbms1 (Heterocephalus glaber - naked mole-rat) |
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Variants
.
Variants in Rbms1
6543 total Variants 
|
